778 related articles for article (PubMed ID: 32524991)
1. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
[TBL] [Abstract][Full Text] [Related]
3. Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER).
Gevaert P; Bachert C; Maspero JF; Cuevas M; Steele D; Acharya S; Altman P
J Allergy Clin Immunol; 2022 May; 149(5):1675-1682.e3. PubMed ID: 35094848
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
5. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ
Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852
[TBL] [Abstract][Full Text] [Related]
7. Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
[TBL] [Abstract][Full Text] [Related]
8. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588
[No Abstract] [Full Text] [Related]
9. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
[TBL] [Abstract][Full Text] [Related]
10. [Short-term efficacy of anti-IgE monoclonal antibody in patients with recurrent chronic rhinosinusitis with nasal polyps combined with asthma].
Shen S; Lou HF; Yan B; Wang Y; Cao FF; Xiong W; Wang CS; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 56(10):1035-1041. PubMed ID: 34666463
[No Abstract] [Full Text] [Related]
11. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
Price CPE; Guo A; Stevens WW; Cousens L; Vu TT; Suh LA; Erickson KA; Conley D; Grammer LC; Kern RC; Tan BK; Kato A; Schleimer RP; Smith SS; Welch KC; Peters AT
Clin Exp Allergy; 2022 Jul; 52(7):859-867. PubMed ID: 35524339
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab is effective in nasal polyposis with or without asthma, a real-life study.
Tat TS
World Allergy Organ J; 2022 Aug; 15(8):100670. PubMed ID: 36017064
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
Dharmarajan H; Falade O; Lee SE; Wang EW
Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J;
Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial.
Zhang Y; Yan B; Shen S; Song X; Jiang Y; Shi L; Zhao C; Yang Y; Jiang L; Li J; Ye J; Liu J; Wan L; Yang Y; Chen J; Liu F; Su L; Xu Y; Tan G; Yu S; Zhang Y; Wang L; Liu S; Yan H; Liu W; Chen B; Wang C; Zhang L
EClinicalMedicine; 2023 Jul; 61():102076. PubMed ID: 37483544
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma.
Paçacı Çetin G; Arslan B; Yılmaz İ
J Asthma; 2024 Jan; 61(1):20-26. PubMed ID: 37437223
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
[TBL] [Abstract][Full Text] [Related]
18. Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE.
Mullol J; Lund VJ; Wagenmann M; Han JK; Sousa AN; Smith SG; Mayer B; Chan RH; Fokkens WJ
Rhinology; 2024 Jun; 62(3):320-329. PubMed ID: 38217844
[TBL] [Abstract][Full Text] [Related]
19. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
Hopkins C; Mullol J; Khan AH; Lee SE; Wagenmann M; Hellings P; Fokkens W; Msihid J; Nair R; Kamat S; Nash S; Radwan A; Jacob-Nara JA; Deniz Y; Rowe PJ
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1173-1182. PubMed ID: 38156522
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
